Medincell (XPAR:MEDCL) Total Liabilities : €76.24 Mil (As of Sep. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Medincell Total Liabilities?

Medincell's Total Liabilities for the quarter that ended in Sep. 2023 was €76.24 Mil.

Medincell's quarterly Total Liabilities increased from Sep. 2022 (€58.85 Mil) to Mar. 2023 (€71.63 Mil) and increased from Mar. 2023 (€71.63 Mil) to Sep. 2023 (€76.24 Mil).

Medincell's annual Total Liabilities increased from Mar. 2021 (€54.48 Mil) to Mar. 2022 (€57.67 Mil) and increased from Mar. 2022 (€57.67 Mil) to Mar. 2023 (€71.63 Mil).

Medincell Total Liabilities Historical Data

The historical data trend for Medincell's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medincell Total Liabilities Chart

Medincell Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Total Liabilities

Get a 7-Day Free Trial

31.74

43.27

54.48

57.67

71.63

Medincell Semi-Annual Data
	Mar16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Total Liabilities	Get a 7-Day Free Trial										56.43	57.67	58.85	71.63	76.24

Medincell Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Medincell's Total Liabilities for the fiscal year that ended in Mar. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	57.025	+	(14.252	+	0.0019999999999963
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0.354)
	=	71.63

Total Liabilities	=	Total Assets (A: Mar. 2023 )	-	Total Equity (A: Mar. 2023 )
	=	29.339	-	-42.294
	=	71.63

Medincell's Total Liabilities for the quarter that ended in Sep. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	19.821	+	(53.175	+	2.829
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0.411)
	=	76.24

Total Liabilities	=	Total Assets (Q: Sep. 2023 )	-	Total Equity (Q: Sep. 2023 )
	=	50.489	-	-25.747
	=	76.24

Medincell Total Liabilities Related Terms

Thank you for viewing the detailed overview of Medincell's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Medincell (XPAR:MEDCL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medincell SA (XPAR:MEDCL) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

MEB:Germany

Address

3 rue des Freres Lumiere, Jacou, FRA, 34830

Website

https://www.medincell.com

Medincell SA is a technology-based pharmaceutical firm, aims to optimise the efficiency of medical treatments and make them accessible geographically. The company's product portfolio uses BEPO-patented technology to develop controlled, long-acting injectable medical treatments for a number of therapeutic fields. The firm has a single operating segment: ongoing research and development on processes that use biodegradable polymers to enable the controlled and prolonged release of the active principles of drugs into the human body and animals by means of injection.

Medincell (XPAR:MEDCL) Headlines

No Headlines